IL6R and myelodysplastic syndrome: Consistent with these data, immunohistochemical stains in the bone marrow revealed a significant upregulation of IL-6R in most of the bone marrow cells in high-risk MDS compared with control-group individuals and patients with low-risk MDS (Figure 6C).